MAKENZE BILLING: Open Payments
NPI 1811688005 · WICHITA FALLS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$328 in 14 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $147 · 2025 $328
Food & beverage: $328
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 8 | $172 |
| GENZYME CORPORATION | 3 | $81 |
| Blueprint Medicines Corporation | 1 | $34 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $20 |
Products named: DUPIXENT, AYVAKIT, NEFFY, NUCALA.
Industry payments across TX — which companies pay providers there.
